DT‐02‐05: MARKVCID PHASE II: PRIORITIZED CANDIDATE SMALL VESSEL VCID BIOMARKERS SELECTED FOR INDEPENDENT MULTI‐SITE TESTING AND VALIDATION

The World Health Organization reports that 47.5 million people are affected by dementia worldwide. The burden of illness due to dementia approaches crisis proportions. Evidence from epidemiology and pathology studies indicates that damage to the vascular system is associated with an increased risk of many types of dementia and neurodegeneration. The science of vascular contributions to cognitive impairment and dementia (VCID) integrates diverse...